From: The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction
Variables | Total (n = 392) | Flow of the main diagonal branches of LAD | p Value | |
---|---|---|---|---|
loss (TIMI 0–1) (n = 69) | no loss (TIMI 2–3) (n = 323) | |||
Age, years, mean ± SD | 63.9 ± 11.6 | 64.7 ± 12.2 | 63.8 ± 11.4 | 0.60 |
Female, n(%) | 68(17.3) | 14(20.3) | 54(16.7) | 0.48 |
Diabetes, n(%) | 103(26.3) | 24(34.8) | 79(24.5) | 0.08 |
Hypertension, n(%) | 232(59.2) | 38(55.1) | 194(60.1) | 0.44 |
Smoking history, n(%) | 164(41.8) | 22(31.9) | 142(44) | 0.07 |
Stroke, n(%) | 26(6.6) | 6(8.7) | 20(6.2) | 0.45 |
Family history of CAD, n(%) | 8(2) | 0 | 8(2.5) | 0.36 |
Previous CAD, n(%) | 26(6.6) | 6(8.7) | 20(6.2) | 0.43 |
Valve calcification, n(%) | 86(21.9) | 13(18.8) | 73(22.6) | 0.49 |
Time from symptom onset to hospital, hours | 6(4–10) | 6(4–9) | 6(4–10) | 0.35 |
0-3 h, n(%) | 88(22.4) | 15(21.7) | 73(22.6) | 0.42 |
3-6 h, n(%) | 117(29.8) | 25(36.2) | 92(28.5) | |
6-12 h, n(%) | 187(47.7) | 29(42) | 158(48.9) | |
LVEF, %, mean ± SD | 47.4 ± 13.2 | 41 ± 18.3 | 48.8 ± 11.4 | 0.003 |
Killip class> 2, n(%) | 16(4.1) | 8(11.6) | 8(2.5) | 0.001 |
SBP, mmHg, mean ± SD | 123 ± 31.6 | 109.0 ± 34.3 | 126.1 ± 30.2 | 0.36 |
TC, mmol/L, mean ± SD | 4.4 ± 1.1 | 4.6 ± 1.3 | 4.3 ± 0.9 | 0.09 |
LDL-C, mmol/L | 2.6(2–3.2) | 2.5(1.7–3.3) | 2.5(1.9–3.2) | 0.89 |
CRP, mg/L | 6.7(3–12.1) | 4.2(1–10.2) | 6.6(3–10.8) | 0.23 |
Scr, μmol/L | 68.5(57–82.8) | 73.5(63.8–86) | 71(60–87) | 0.71 |
cTNT, ng/ml | 0.2(0.05–0.75) | 0.11(0.04–0.64) | 0.26(0.06–0.78) | 0.08 |
CKMB, U/L | 27(14–63) | 21(14.8–104) | 30.5(16–69.3) | 0.46 |
NT-proBNP, pg/ml | 227.6(59.4–922.9) | 126.1(49.4–429.5) | 236.4(57.7–1142.3) | 0.16 |
Medications during hospital | ||||
Aspirin, n(%) | 363(92.6) | 64(92.8) | 299(92.6) | 0.96 |
Clopidogrel, n(%) | 247(63) | 41(59.4) | 206(63.8) | 0.50 |
Ticagrelor, n(%) | 145(37) | 28(40.6) | 117(36.2) | 0.49 |
GPIIb/IIIa receptor antagonists, n(%) | 248(63.3) | 44(63.8) | 204(63.2) | 0.91 |
AECI/ARB, n(%) | 381(97.2) | 67(97.1) | 314(97.2) | 0.98 |
β-receptor blocker, n(%) | 387(98.7) | 68(98.6) | 319(98.8) | 0.98 |
Statin, n(%) | 392(100) | 69(100) | 323(100) | 0.99 |
Hospital stay, days, mean ± SD | 8.1 ± 3.8 | 8.9 ± 4 | 7.9 ± 3.8 | 0.07 |